OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 11th at 4:30 p.m. Pacific time.

The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com

Staff

Recent Posts

Leader Healthcare Implements SAP S/4HANA Public Cloud With Accely To Drive Operational Excellence

With SAP S/4HANA Public Cloud, the foremost healthcare equipment supplier in the UAE starts a…

2 hours ago

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI)…

23 hours ago

D-Bal Max 2025: Exploring the Science and Safety behind a Popular And Legal Dianabol Steroid For Muscle Growth

D-bal-max D-Bal MAX Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…

23 hours ago